Axovant Sciences Ltd (AXGT) Stock Price, Quote, News and Overview
NASDAQ:AXGT - Nasdaq -
AXGT Quote, Performance and Key Statistics
2.1
-0.05 (-2.33%)
The current stock price of AXGT is 2.1 null. In the past month the price decreased by -38.95%. In the past year, price decreased by -55.32%.
About AXGT
Company Profile
Axovant Sciences Ltd. is a biopharmaceutical company which focuses on the acquisition, development and commercialization of therapeutics for the treatment of neurodegenerative disorders. Its product candidate includes RVT-101 which is in different clinical trial for the treatment of Alzheimer's disease and other forms of dementia. Axovant Sciences Ltd. is based in Hamilton, Bermuda.
Company Info
Axovant Sciences Ltd
11-12 ST. JAMES`S SQUARE SUITE 1 3RD FLOOR
LONDON X0 10036
CEO: Pavan Cheruvu
Phone: 833-296-8268
Axovant Sciences Ltd / AXGT FAQ
What is the stock price of Axovant Sciences Ltd today?
The current stock price of AXGT is 2.1 null. The price decreased by -2.33% in the last trading session.
What is the ticker symbol for Axovant Sciences Ltd stock?
The exchange symbol of Axovant Sciences Ltd is AXGT and it is listed on the Nasdaq exchange.
On which exchange is AXGT stock listed?
AXGT stock is listed on the Nasdaq exchange.
What is Axovant Sciences Ltd worth?
Axovant Sciences Ltd (AXGT) has a market capitalization of 99.22M null. This makes AXGT a Micro Cap stock.
What are the support and resistance levels for Axovant Sciences Ltd (AXGT) stock?
Axovant Sciences Ltd (AXGT) has a support level at 1.92 and a resistance level at 2.23. Check the full technical report for a detailed analysis of AXGT support and resistance levels.
Should I buy Axovant Sciences Ltd (AXGT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AXGT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AXGT, evaluating the profitability, health, valuation and growth aspects
- Axovant Sciences Ltd (AXGT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Axovant Sciences Ltd (AXGT) Sales and EPS estimates to see what analysts future expectations are.
- Axovant Sciences Ltd (AXGT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Axovant Sciences Ltd (AXGT) Insider and Institutional Ownership to learn about the owners and their transactions.
- Axovant Sciences Ltd (AXGT) Stock Chart to make your own analysis
- Axovant Sciences Ltd (AXGT) Latest news and press-releases to stay up to date.
Does Axovant Sciences Ltd (AXGT) stock pay dividends?
AXGT does not pay a dividend.
What is the Price/Earnings (PE) ratio of Axovant Sciences Ltd (AXGT)?
Axovant Sciences Ltd (AXGT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.97).
AXGT Technical Analysis
AXGT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AXGT. AXGT has a bad profitability rating. Also its financial health evaluation is rather negative.
AXGT Financial Highlights
Over the last trailing twelve months AXGT reported a non-GAAP Earnings per Share(EPS) of -1.9699999999999998. The EPS increased by 67.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -74.84% | ||
| ROE | N/A | ||
| Debt/Equity | 0.11 |
AXGT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 92% to AXGT. The Buy consensus is the average rating of analysts ratings from 5 analysts.